AzTrials
AzTrials

Alcohol DrinkingPhase 2/3NCT00547963

Brief Counseling to Reduce Injuries Among Emergency Department Patients Who Report Alcohol and Substance Use

A Phase 2/3 study testing brief counseling in people with Alcohol Drinking and Marijuana Smoking, run by National Institute on Alcohol Abuse and Alcoholism (NIAAA) at 1 site in United States.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The purpose of this study is to determine the effectiveness of two brief counseling sessions delivered to emergency department (ED) patients who report conjoint alcohol and marijuana use, in reducing injuries and other negative consequences, in comparison to an assessment only group. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Alcohol Drinking, Marijuana Smoking
What is being tested?
brief counseling
Could I receive a placebo?
No, everyone receives an active treatment
How many people
554 participants
Where
1 siteUnited States
Study dates
Dec 2003to Dec 2008
Phase
Phase 2/3
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Male and female outpatients 18 years of age or older.
  • Participants will have a current DSM-IV diagnosis of alcohol dependence.
  • Participants will have signed a witnessed informed consent.

Who cannot join

  • Participants who meet current DSM-IV criteria for bipolar disorder, schizophrenia, dementia, or a psychological disorder requiring medication.
  • Participants who have had more than seven days of inpatient treatment for substance use disorders in the 30 days previous to randomization.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Injury Prevention Center, Rhode Island Hospital, Brown University

    Providence, Rhode Island, 02903

Other trials in United States

About this study

Official title: Reducing Injury, ETOH and THC Use Among ED Patients

The purpose of this study is to determine the effectiveness of two brief counseling sessions delivered to emergency department (ED) patients who report conjoint alcohol and marijuana use, in reducing injuries and other negative consequences, in comparison to an assessment only group.

Read the detailed description

Alcohol and substance use remain a significant predictor of injuries, health and psychosocial consequences.

ED patients who were not being treated for critical conditions were asked about their use of alcohol and marijuana. Patients who self-reported the use of both substances were asked to participate in the study.

Recruited participants were given a baseline assessment and then randomized a treatment or a control condition. The treatment condition consisted of two 40 minute sessions of brief counseling. The first session took place in the ED the second session occurred within two weeks of being seen in the ED.

Participants completed assessments three and twelve months after being recruited in the ED. The primary dependent variables for this study are 12 month injuries and self-reported levels of negative life consequences associated with alcohol and marijuana use.

Being tested
brief counseling
Keywords
Alcohol Drinking, Marijuana Smoking, Substance Use, Emergency Department (ED)
Medical subject headings
Alcohol Drinking, Marijuana Smoking, Substance-Related Disorders, Emergencies

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • brief counselingBehavioural

    baseline assessment + two 40 minute sessions of brief counseling

Study groups in NCT00547963
Study groupRoleWhat they receive
1Experimentaltwo brief counseling sessions delivered to ED patients who report conjoint alcohol and marijuana use
Receives: Behavioral: brief counseling

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Substance use; injuries, alcohol and marijuana negative consequences

    Measured: 3 and 12 months

Secondary outcomes (1)
  1. Mediators and moderators of treatment efficacy

    Measured: 3 and 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Oct 2007 (estimated)
  2. Study startDec 2003
  3. Primary completionDec 2008 (estimated)
  4. Study completionDec 2008 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2/3
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Factorial
Masking
None (open label)
Enrolment
554 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00547963
Sponsor's protocol ID
NIAAA-BAI-013709
Other IDs
NIH Grant number 5R01AA013709
Status last verified
Oct 2008
First submitted
19 Oct 2007
Last updated
8 Oct 2008
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A Phase 2/3 study testing brief counseling in people with Alcohol Drinking and Marijuana Smoking, run by National Institute on Alcohol Abuse and Alcoholism (NIAAA) at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 8 Oct 2008. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this combined phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Substance use; injuries, alcohol and marijuana negative consequences (time frame: 3 and 12 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Oct 2008.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in